distillery

Scripps team discovers RNA-targeting small molecule for myotonic and corneal dystrophies

DISEASE CATEGORY: Musculoskeletal; ophthalmic disease INDICATION: Myotonic dystrophy type 1 (DM1); ophthalmic A Scripps Research team led by Expansion Therapeutics Inc. co-founder Matthew Disney has designed an RNA-targeting small molecule that could treat DM1 and Fuchs...

Targeting an mRNA epigenetic reader protein for breast cancer brain metastasis

DISEASE CATEGORY: Cancer INDICATION: Breast cancer Inhibiting the RNA epigenetic reader protein YTHDF3, which recognizes the m6A methylation mark, could treat brain metastasis in breast cancer. In breast cancer patients, high expression of YTHDF3 mRNA was associated with...

SQSTM1, INSR identified as targets in sepsis

DISEASE CATEGORY: Infectious disease INDICATION: Sepsis Inhibiting the scaffold protein SQSTM1 or its extracellular receptor INSR could treat bacterial sepsis. Among 40 patients with bacterial sepsis, survivors had lower peripheral blood mononuclear cell mRNA levels of SQSTM1...

Inhibiting BMI1 and BCL-2 to treat diffuse intrinsic pontine glioma

DISEASE CATEGORY: Cancer INDICATION: Brain cancer Inhibiting epigenetic regulator BMI1 alone or in combination with BCL-2 inhibition could treat diffuse intrinsic pontine glioma (DIPG), an aggressive childhood brain cancer. A screen in two human DIPG...

Metalloprotease MYSM1 identified as protective factor in lupus

DISEASE CATEGORY: Autoimmune disease INDICATION: Lupus Promoting the expression of the metalloprotease MYSM1 could treat systemic lupus erythematous (SLE). MYSM1 mRNA and protein levels were lower in peripheral blood mononuclear cells (PBMCs) from 14 SLE...

Neuraly’s GLP-1R agonist NLY01 for ocular hypertension

DISEASE CATEGORY: Ophthalmic disease INDICATION: Ocular hypertension Penn researchers showed that NLY01 from Neuraly Inc., could treat ocular hypertension. In mice modelling ocular hypertension, the pegylated exenatide reduced retinal ganglion cell death and mRNA levels of...

Oligodendrocyte-derived extracellular vesicles for multiple sclerosis

DISEASE CATEGORY: Autoimmune disease INDICATION: Multiple sclerosis (MS) Extracellular vesicles derived from oligodendrocytes could prevent and treat MS. The vesicles were collected from the supernatant of mature oligodendrocytes differentiated from mouse oligodendrocyte progenitor cells. In mouse models...

A phosphofructokinase inhibitor for a genetic mitochondrial syndrome

DISEASE CATEGORY: Endocrine/metabolic INDICATION: Mitochondrial disease A PFKM inhibitor could treat MELAS (mitochondrial encephalopathy, lactic acidosis and stroke-like episodes) syndrome, which is most often caused by mutations in mitochondrially encoded MT-TL1. A cell-based screen of 17,568 small...

Blocking PCSK9 alone or with anti-PD-1 therapies for cancer

DISEASE CATEGORY: Cancer INDICATION: Breast cancer; colorectal cancer; melanoma PCSK9 inhibition could treat melanoma, breast, colorectal and other cancers, and enhance the efficacy of PD-1 inhibitors. In cohorts of melanoma, liver, pancreatic, bladder, lung, kidney and...

Apoptosis regulator MCL1 as an Alzheimer’s target

DISEASE CATEGORY: Neurology INDICATION: Alzheimer’s disease (AD) Blocking MCL1, which inhibits apoptosis, could treat Alzheimer’s disease. A high-throughput screen in HEK cells of 2,204 drug candidates or FDA-approved drugs yielded 20 agents, including an MCL1...

Inhibiting vesicular trafficking protein SURF4 to treat atherosclerosis

DISEASE CATEGORY: Cardiovascular INDICATION: Atherosclerosis Targeting the ER cargo receptor SURF4 could treat atherosclerosis and dyslipidemia. In a mouse model of atherosclerosis, liver-specific heterozygous or homozygous SURF4 deletion reduced cholesterol and triglyceride levels in plasma...

Skeletal muscle-specific derivative of myosin inhibitor tool compound for spasticity and muscle stiffness

DISEASE CATEGORY: Musculoskeletal INDICATION: Spasticity A small molecule inhibitor of fast skeletal muscle myosin isoforms could treat spasticity and muscle stiffness. The compound is a morpholine derivative of blebbistatin, a tool compound inhibitor of multiple...

Blocking ROR2 for osteoarthritis

DISEASE CATEGORY: Musculoskeletal INDICATION: Osteoarthritis Inhibiting the tyrosine protein kinase receptor ROR2 could treat osteoarthritis. Expression levels of the ROR2 ligand WNT5A were higher in human osteoarthritic cartilage than in healthy cartilage. In a mouse fibroblast...

TREML4 as a sepsis target

DISEASE CATEGORY: Infectious disease INDICATION: Sepsis Inhibiting the myeloid receptor TREML4 could treat sepsis. In mice with acute polymicrobial sepsis, systemic knockout of TREML4 prevented macroscopic thymic involution and increased proportions of mature and immature...

Targeting water channel AQP1 for hypertrophic cardiomyopathy

DISEASE CATEGORY: Cardiovascular INDICATION: Cardiomyopathy Inhibiting AQP1, a water channel expressed in cardiac and vascular tissues, could treat hypertrophic cardiomyopathy. Among 26 patients with aortic stenosis, high AQP1 mRNA expression in cardiac biopsies was associated with...